The role of Pitx2 and Pitx3 in muscle stem cells gives new insights into P38α MAP kinase and redox regulation of muscle regeneration

  1. Aurore Lhonore  Is a corresponding author
  2. Pierre-Henri Commère
  3. Elisa Negroni
  4. Giorgia Pallafacchina
  5. Bertrand Friguet
  6. Jacques Drouin
  7. Margaret Buckingham
  8. Didier Montarras  Is a corresponding author
  1. CNRS UMR 3738, Institut Pasteur, France
  2. Institut Pasteur, France
  3. Sorbonne Universités, Université Pierre et Marie Curie Université Paris 06, INSERM UMRS974, France
  4. Italian National Research Council (CNR) Neuroscience Institute, Italy
  5. CNRS UMR 8256, INSERM ERL U1164, France
  6. Institut de Recherches Cliniques de Montréal, France

Abstract

Skeletal muscle regeneration depends on satellite cells. After injury these muscle stem cells exit quiescence, proliferate and differentiate to regenerate damaged fibres. We show that this progression is accompanied by metabolic changes leading to increased production of reactive oxygen species (ROS). Using Pitx2/3 single and double mutant mice that provide genetic models of deregulated redox states, we demonstrate that moderate overproduction of ROS results in premature differentiation of satellite cells while high levels lead to their senescence and regenerative failure. Using the ROS scavenger, N-Acetyl-Cysteine, (NAC) in primary cultures we show that a physiological increase in ROS is required for satellite cells to exit the cell cycle and initiate differentiation through the redox activation of p38a MAP kinase. Subjecting cultured satellite cells to transient inhibition of P38a MAP kinase in conjunction with NAC treatment leads to their rapid expansion, with striking improvement of their regenerative potential in grafting experiments.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures and supplement figures.

The following previously published data sets were used

Article and author information

Author details

  1. Aurore Lhonore

    Department of Developmental and Stem Cell Biology, CNRS UMR 3738, Institut Pasteur, Paris, France
    For correspondence
    alhonore@hotmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6371-4455
  2. Pierre-Henri Commère

    Platform of Cytometry, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  3. Elisa Negroni

    Center for Research in Myology, Sorbonne Universités, Université Pierre et Marie Curie Université Paris 06, INSERM UMRS974, Paris, France
    Competing interests
    No competing interests declared.
  4. Giorgia Pallafacchina

    Italian National Research Council (CNR) Neuroscience Institute, Padova, Italy
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9766-5970
  5. Bertrand Friguet

    Biological Adaptation and Aging-IBPS, CNRS UMR 8256, INSERM ERL U1164, Paris, France
    Competing interests
    No competing interests declared.
  6. Jacques Drouin

    Laboratory of Molecular Genetics, Institut de Recherches Cliniques de Montréal, Montréal, France
    Competing interests
    No competing interests declared.
  7. Margaret Buckingham

    Department of Developmental and Stem Cell Biology, CNRS UMR 3738, Institut Pasteur, Paris, France
    Competing interests
    Margaret Buckingham, Reviewing editor, eLife.
  8. Didier Montarras

    Department of Developmental and Stem Cell Biology, CNRS UMR 3738, CNRS UMR 3738, Institut Pasteur, Paris, France
    For correspondence
    didier.montarras@pasteur.fr
    Competing interests
    No competing interests declared.

Funding

Agence Nationale de la Recherche (REGSAT)

  • Margaret Buckingham

AFM-Téléthon

  • Didier Montarras

AFM-Téléthon (Postdoc Fellowship)

  • Aurore Lhonore

Agence Nationale de la Recherche (ANR-10-LABX-73)

  • Margaret Buckingham

Seventh Framework Programme (OptiStem 223098)

  • Margaret Buckingham

Seventh Framework Programme (Marie Curie IRG 248496)

  • Aurore Lhonore

Fondation pour la Recherche Médicale (Postdoc Fellowship)

  • Aurore Lhonore

Fondation pour la Recherche Médicale (Postdoc Fellowship)

  • Giorgia Pallafacchina

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were approved and conducted in accordance with the Institut Pasteur animal ethics committee (CEEA Institut Pasteur n{degree sign}2013-0017 and APAFIS #2455 2015 1122133311) following the regulations of the Ministry of Agriculture and the European Community guidelines. All surgery were performed under Ketamine /Xylazine anesthesia and and every effort was made to minimize suffering.

Copyright

© 2018, Lhonore et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,610
    views
  • 544
    downloads
  • 59
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Aurore Lhonore
  2. Pierre-Henri Commère
  3. Elisa Negroni
  4. Giorgia Pallafacchina
  5. Bertrand Friguet
  6. Jacques Drouin
  7. Margaret Buckingham
  8. Didier Montarras
(2018)
The role of Pitx2 and Pitx3 in muscle stem cells gives new insights into P38α MAP kinase and redox regulation of muscle regeneration
eLife 7:e32991.
https://doi.org/10.7554/eLife.32991

Share this article

https://doi.org/10.7554/eLife.32991

Further reading

    1. Cell Biology
    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology
    2. Developmental Biology
    Sarah Y Coomson, Salil A Lachke
    Insight

    A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.